Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation
Fujimoto AB, Keskinocak P, Yildirim I. Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation. Vaccine 2021, 39: 5055-5063. PMID: 34274126, PMCID: PMC8233959, DOI: 10.1016/j.vaccine.2021.06.067.Peer-Reviewed Original ResearchConceptsInfection attack rateAntibody testingSARS-CoV-2-specific antibodiesSpecific antibody testingAttack rateCOVID-19 vaccineSingle-dose vaccineCOVID-19 vaccine allocationDose vaccineSerology testingLimited vaccinesEligible individualsVaccine deploymentVaccination planVaccine supplySusceptible individualsNumber of casesRecovered (SIR) compartmental modelPeak dayUse of antibodiesVaccine allocationVaccinePeak infectionVaccinationSpecific antibodies